Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

DemeRx Receives MHRA Approval for DMX-1002 Study for Opioid Use Disorder

americanpharmaceuticalreviewMarch 17, 2021

Tag: DemeRx , DMX-1002 , ibogaine , ATAI

PharmaSources Customer Service